Welcome to the Activaero website,
welcome to FAVORITE inhalation!
Activaero is the inventor of FAVORITE, the most precise and efficient technology for delivering aerosolized drugs to the lungs.
Under the trade mark of AKITA® Activaero is developing and producing inhalation systems which enable the use of FAVORITE in the therapy of pulmonary diseases and the development of new inhalant drugs. Beyond that, Activaero is a center of excellence in aerosol medicine and supports pharma and biotech companies with its technology and services.
AKITA® JET
"The Reference class for jet nebulizers"
- precise lung deposition
- 50% reduced wastage
of drug
Pre-Clinic, Clinic, Market - Partnering with Activaero
News
Activaero appoints Christian Pangratz as new Chief Business Officer
Activaero GmbH, a leader in controlled breathing inhalation technologies and therapeutics, today announced the appointment of Christian M. Pangratz as Chief Business Officer.[more]
Activaero raises EUR 5.0 Million ($ 6.8 Million) in a second closing series a round led by LSP
Gemuenden/Wohra, February 16, 2011 - Activaero today announced that it has closed a further financing round of 5.0 Mio Euros with LSP Life Sciences Partners from the Netherlands. Activaero will use the proceeds to further develop...[more]
